RxDoctor Payments Data

Giancarlo Checa, MD

Anesthesiology · Englewood, CONPI 1003889833

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 73.7% of it on its own, with 59 other manufacturers making up the rest. Reporting peaked in 2022 at $34,748 and has fallen 91.2% since, to $3,041 in 2025. Among anesthesiology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$88,877in general payments, 2019–2025

Across 965 payments — averaging $92.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$65K
  • Saluda Medical Americas, Inc.$4K
  • AbbVie$2K
  • MML US, Inc.$1K
  • Abbott$1K
  • Southern Spine, LLC$1K
  • plus $13K from 54 others

What the payments were for

  • Consulting fees$6,9508%
  • Speaking & faculty fees$46,96353%
  • Travel & lodging$5,9027%
  • Food & beverage$29,04233%
  • Education$200%
  • Gifts$00%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific182$65,489
Saluda Medical Americas, Inc.25$4,000
AbbVie(2 entities)152$2,459
MML US, Inc.11$1,438
Abbott18$1,176
Southern Spine, LLC1$1,000
Collegium Pharmaceutical, Inc.69$990
Scilex Pharmaceuticals Inc.54$947
Relievant Medsystems, Inc.9$937
Medtronic(2 entities)12$922
Vertos Medical, Inc.15$783
Painteq LLC9$779
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC42$629
SPR Therapeutics, Inc9$535
Pfizer33$529
Amgen(2 entities)19$513
Nevro Corp.32$483
Nalu Medical, Inc.5$397
Lundbeck LLC18$373
Vertiflex, Inc.8$355
Lilly USA, LLC22$328
Spinal Simplicity, LLC4$325
Zyla Life Sciences, Inc.67$324
Biohaven Pharmaceuticals, Inc.11$303
Biodelivery Sciences International, Inc.16$237
GRT US Holding, Inc.15$220
Stimwave Technologies Incorporated5$193
Averitas Pharma Inc.8$179
Pacira Therapeutics, Inc.5$173
Stryker1$163
Biohaven Pharmaceutical Holding Company Ltd.10$155
Axonics, Inc.1$148
Vertex3$118
Teva Pharmaceuticals USA, Inc.7$114
Almatica Pharma LLC5$94
Organogenesis Inc.1$94
Novartis5$86
IBSA Pharma Inc.4$78
Supernus Pharmaceuticals, Inc.4$60
Upsher-smith Laboratories LLC4$58
Sentynl Therapeutics, Inc.4$54
Redhill Biopharma Inc.4$53
Shionogi Inc3$50
Merck3$50
Avanir Pharmaceuticals, Inc.3$49
Radius Health, Inc.3$48
Si-bone, Inc.2$44
Arbor Pharmaceuticals, Inc.3$42
AstraZeneca3$41
MDD US Operations, LLC3$40
Assertio Therapeutics, Inc.2$31
Tonix Medicines, Inc.1$31
Eisai Inc.2$26
Zimmer Biomet1$21
Kaleo, Inc.1$20
Daiichi Sankyo Inc.1$19
Bioventus LLC1$18
Axsome Therapeutics, Inc.1$15
Baudax Bio Inc.1$14
Takeda Pharmaceuticals U.S.A., Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$88,877 in reported general payments places this provider in the 95th percentile of 921 anesthesiology providers in Colorado.

See all anesthesiology providers in Colorado

Medicare billing

Part B allowed, 2024
$348,157
Medicare patients
691
Services billed
3,226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl13$5,743
Gabapentin159$3,727
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen77$2,208
Oxycodone Hcl118$1,894
Lidocaine12$1,677
Pregabalin34$1,216
Morphine Sulfate ErMorphine Sulfate43$1,034
Celecoxib26$964
Methocarbamol30$930
Tramadol Hcl ErTramadol Hcl11$839
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen32$731
Tizanidine Hcl56$677
Tramadol Hcl53$498
Baclofen27$396
Duloxetine Hcl23$379

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$990$5,74313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 921 anesthesiology providers in Colorado.

Other anesthesiology in Englewood

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →